Increased interleukin‐17 production in patients with systemic sclerosis

…, H Sano, H Endo, H Shinkai, Y Nawata… - … : Official Journal of …, 2000 - Wiley Online Library
Objective To determine the role of a novel T cell–derived cytokine, interleukin‐17 (IL‐17),
which activates fibroblasts and endothelial cells, in the pathogenesis of systemic sclerosis …

Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment

K Oinuma, Y Harada, Y Nawata… - Annals of the …, 2001 - ard.bmj.com
OBJECTIVES To investigate the actual time of onset of osteonecrosis (ON) after high dose
corticosteroid treatment in systemic lupus erythematosus (SLE). METHODS 72 patients with …

Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.

Y Nawata, K Kurasawa, K Takabayashi… - The Journal of …, 1999 - europepmc.org
Objective To determine the characteristics of corticosteroid resistant interstitial pneumonitis
(IP) in dermatomyositis (DM) and polymyositis (PM), and to evaluate the effect of …

Osteonecrosis of the femoral head: a prospective study with MRI

…, S Iida, T Akita, H Moriya, Y Nawata - The Journal of Bone …, 1997 - boneandjoint.org.uk
We performed a prospective study using MRI to evaluate early necrosis of the femoral head
in 48 patients receiving high-dose corticosteroids for the treatment of various autoimmune …

Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood …

…, I Iwamoto, T Umibe, Y Nawata… - Arthritis & …, 2014 - Wiley Online Library
Objective The aim of this prospective multicenter study was to identify biomarkers that can
be used to predict therapeutic responses to tocilizumab in patients with rheumatoid arthritis …

Activation of pulmonary T cells in corticosteroid-resistant and-sensitive interstitial pneumonitis in dermatomyositis/polymyositis

K Kurasawa, Y Nawata, K Takabayashi… - Clinical & …, 2002 - academic.oup.com
To study the activation states and cytokine profiles of pulmonary T cells in corticosteroid-
resistant and corticosteroid-sensitive interstitial pneumonitis (IP) in dermatomyositis …

Suppression of methamphetamine-seeking behavior by nicotinic agonists

T Hiranita, Y Nawata, K Sakimura… - Proceedings of the …, 2006 - National Acad Sciences
To understand the mechanism of methamphetamine (MAP) craving from the viewpoint of
nicotinic acetylcholinergic transmission, we examined the responsible site of the brain for …

[HTML][HTML] Latent class analysis of 216 patients with adult-onset Still's disease

…, K Kurasawa, D Nakagomi, Y Nawata… - Arthritis Research & …, 2022 - Springer
Abstract Background Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory
disease which encompasses patients with heterogenous presentation and a wide range of …

Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.

…, A Sakamoto, Y Kita, K Kurasawa, Y Nawata… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To study the regulatory role of CD4-CD8-double-negative (DN) invariant T cell
receptor (TCR) Valpha24JalphaQ T cells, a human counterpart of murine NK 1+ T cells, in …

Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock

Y Nawata, K Kitaichi, T Yamamoto - Pharmacology Biochemistry and …, 2012 - Elsevier
Recent evidence suggests the involvement of corticotropin-releasing factor (CRF) in drug
abuse. Here, we evaluated whether CRF modulates the reinstatement of methamphetamine …